Patients News | pharmaphorum

News

Hilversum, The Netherlands - April 03, 2014. Image of a touch screen Android phone with social media apps.

ABPI code updated with first social media guidance

Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time.

News

NICE recommends first CAR-T cell therapy on NHS in England

Gilead Sciences and Kite, a Gilead company, have announced that the National Institute for Health and Care Excellence (NICE) has recommended Yescarta (axicabtagene ciloleucel; axi-cel) for

News

Amazon unveils $5 subscription service for generics

Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients' homes in

News

blood_pressure_cuff_mockup_graphics_unsplash

Unmedicated nation: COVID cuts heart drug use in GB

Hundreds of thousands of people in Great Britain have missed out on receiving medication that could protect them from serious cardiovascular disease (CVD) as a result of the COVID-19 pandem

News

NICE backs Alnylam's Amvuttra for rare form of amyloidosis

Alnylam's gene-silencing drug Amvuttra has been recommended as a treatment for hereditary transthyretin-related (ATTR) amyloidosis by NICE, paving the way for the drug to be made available

News

Digital monitoring could be a leveller in diabetes therapy

A digital tool developed by DarioHealth has been shown to help patients with type 2 diabetes manage their blood sugar more effectively, regardless of their demographic background, in a new

ABPI code updated with first social media guidance

NICE recommends first CAR-T cell therapy on NHS in England

Amazon unveils $5 subscription service for generics

Unmedicated nation: COVID cuts heart drug use in GB

NICE backs Alnylam's Amvuttra for rare form of amyloidosis

Digital monitoring could be a leveller in diabetes therapy

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks